BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27485270)

  • 1. Development of a scintillation proximity binding assay for high-throughput screening of hematopoietic prostaglandin D2 synthase.
    Meleza C; Thomasson B; Ramachandran C; O'Neill JW; Michelsen K; Lo MC
    Anal Biochem; 2016 Oct; 511():17-23. PubMed ID: 27485270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors.
    Deaton DN; Do Y; Holt J; Jeune MR; Kramer HF; Larkin AL; Orband-Miller LA; Peckham GE; Poole C; Price DJ; Schaller LT; Shen Y; Shewchuk LM; Stewart EL; Stuart JD; Thomson SA; Ward P; Wilson JW; Xu T; Guss JH; Musetti C; Rendina AR; Affleck K; Anders D; Hancock AP; Hobbs H; Hodgson ST; Hutchinson J; Leveridge MV; Nicholls H; Smith IED; Somers DO; Sneddon HF; Uddin S; Cleasby A; Mortenson PN; Richardson C; Saxty G
    Bioorg Med Chem; 2019 Apr; 27(8):1456-1478. PubMed ID: 30858025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate-induced product-release mechanism of lipocalin-type prostaglandin D synthase.
    Shimamoto S; Nakagawa Y; Hidaka Y; Maruno T; Kobayashi Y; Kawahara K; Yoshida T; Ohkubo T; Aritake K; Kaushik MK; Urade Y
    Biochem Biophys Res Commun; 2021 Sep; 569():66-71. PubMed ID: 34237429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of indole inhibitors of human hematopoietic prostaglandin D2 synthase (hH-PGDS).
    Edfeldt F; Evenäs J; Lepistö M; Ward A; Petersen J; Wissler L; Rohman M; Sivars U; Svensson K; Perry M; Feierberg I; Zhou XH; Hansson T; Narjes F
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2496-500. PubMed ID: 25978964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR resonance assignments of mouse lipocalin-type prostaglandin D synthase/prostaglandin J
    Shimamoto S; Nakahata Y; Hidaka Y; Yoshida T; Ohkubo T
    Biomol NMR Assign; 2022 Oct; 16(2):225-229. PubMed ID: 35445291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.
    Irikura D; Aritake K; Nagata N; Maruyama T; Shimamoto S; Urade Y
    J Biol Chem; 2009 Mar; 284(12):7623-30. PubMed ID: 19131342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hematopoietic prostaglandin D2 synthase (H-PGDS) by an alkaloid extract from Combretum molle.
    Moyo R; Chimponda T; Mukanganyama S
    BMC Complement Altern Med; 2014 Jul; 14():221. PubMed ID: 24996417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin synthase activity of sigma- and mu-class glutathione transferases in a parasitic trematode, Clonorchis sinensis.
    Kim J; Sohn WM; Bae YA
    Parasites Hosts Dis; 2024 May; 62(2):205-216. PubMed ID: 38835261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-quality crystals of human haematopoietic prostaglandin D synthase with novel inhibitors.
    Takahashi S; Tsurumura T; Aritake K; Furubayashi N; Sato M; Yamanaka M; Hirota E; Sano S; Kobayashi T; Tanaka T; Inaka K; Tanaka H; Urade Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jul; 66(Pt 7):846-50. PubMed ID: 20606289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence.
    Urade Y; Eguchi N
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():375-82. PubMed ID: 12432930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematopoietic prostaglandin D synthase inhibitors for the treatment of duchenne muscular dystrophy].
    Kamauchi S; Urade Y
    Brain Nerve; 2011 Nov; 63(11):1261-9. PubMed ID: 22068479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters.
    Trujillo JI; Kiefer JR; Huang W; Day JE; Moon J; Jerome GM; Bono CP; Kornmeier CM; Williams ML; Kuhn C; Rennie GR; Wynn TA; Carron CP; Thorarensen A
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3795-9. PubMed ID: 22546671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase.
    Weber JE; Oakley AJ; Christ AN; Clark AG; Hayes JD; Hall R; Hume DA; Board PG; Smythe ML; Flanagan JU
    Eur J Med Chem; 2010 Feb; 45(2):447-54. PubMed ID: 19939518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type prostaglandin D synthase regulates the trafficking of the PGD
    Binda C; Génier S; Degrandmaison J; Picard S; Fréchette L; Jean S; Marsault E; Parent JL
    J Biol Chem; 2019 Nov; 294(45):16865-16883. PubMed ID: 31575663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hematopoietic prostaglandin D synthase inhibitor complex structures.
    Kado Y; Aritake K; Uodome N; Okano Y; Okazaki N; Matsumura H; Urade Y; Inoue T
    J Biochem; 2012 Apr; 151(4):447-55. PubMed ID: 22418579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin.
    Shimura C; Satoh T; Igawa K; Aritake K; Urade Y; Nakamura M; Yokozeki H
    Am J Pathol; 2010 Jan; 176(1):227-37. PubMed ID: 20008150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.
    Ahmad AS; Ottallah H; Maciel CB; Strickland M; Doré S
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30893431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase.
    Aritake K; Kado Y; Inoue T; Miyano M; Urade Y
    J Biol Chem; 2006 Jun; 281(22):15277-86. PubMed ID: 16547010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel amide and imidazole compounds as potent hematopoietic prostaglandin D
    Olson KL; Holt MC; Ciske FL; Kramer JB; Heiple PE; Collins ML; Johnson CM; Ho CS; Morano MI; Barrett SD
    Bioorg Med Chem Lett; 2021 Feb; 34():127759. PubMed ID: 33383152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.